Share Share Share

Silicane Derivative Increases Doxorubicin Efficacy in an Ovarian Carcinoma Mouse Model: Fighting Drug Resistance

ACS APPLIED MATERIALS & INTERFACES

FOJTŮ, M.; BALVAN, J.; VIČAR, T.; POLANSKÁ, H.; PELTANOVÁ, B.; MATĚJKOVÁ, S.; RAUDENSKÁ, M.; ŠTURALA, J.; MAYORGA BURREZO, P.; MASAŘÍK, M.; PUMERA, M., 2021: Silicane Derivative Increases Doxorubicin Efficacy in an Ovarian Carcinoma Mouse Model: Fighting Drug Resistance. ACS APPLIED MATERIALS & INTERFACES , p. 31355 - 16, doi: 10.1021/acsami.0c20458; FULL TEXT

Research Groups:

• Future Energy and Innovation

CEITEC authors:

• Prof. Martin Pumera, Ph.D.